Accelerate Diagnostics | AXDX - Capital Social Ordinario



Capital Social Ordinario Cambio Fecha
Abbott USD 1.74B 23.39B 2025-09
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Bio-Rad Laboratories USD 26.97M 90K 2025-09
Bruker USD 151.94M 225K 2025-12
Danaher USD 706.9M 600K 2025-12
Illumina USD 152.8M 900K 2025-12
Myriad Genetics USD 93.5M 400K 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Quidel USD 67.9M 200K 2025-09
Revvity USD 113.38M 2.7M 2025-12
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12